Dapivirine Completed Phase 1 / 2 Trials for Acquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT03393468Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults
NCT03239483Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults